Evidence map›Paper›PMID 28693190›Full record

ArticleOncology letters2017

Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.

Xiaodong Xie, Haitao Zhu, Jia Zhang, Meiqin Wang, Li Zhu, Zhen Guo, Wenrong Shen, Dongqing Wang

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Anticancer activity of glycoalkaloids fromFrontiers in pharmacology · 2022
    Review
  7. Article
  8. International journal of molecular medicine · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Xiaodong XieDepartment of Radiology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210000, P.R. China.
Haitao ZhuDepartment of Radiology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Jia ZhangDepartment of Radiology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210000, P.R. China.
Meiqin WangDepartment of Radiology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210000, P.R. China.
Li ZhuDepartment of Radiology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Zhen GuoDepartment of Radiology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210000, P.R. China.
Wenrong ShenDepartment of Radiology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210000, P.R. China.
Dongqing WangDepartment of Radiology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212013, P.R. China.
Jiangsu Cancer Hospital · CNAffiliated Hospital of Jiangsu University · CNJiangsu University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solamargine (SM), a steroidal alkaloid glycoside purified from the Chinese traditional herb

Indexed as

epithelial-to-mesenchymal transitionhepatoblastomainvasionmigrationsolamargine

Identifiers

PMID28693190
PMCPMC5494822
OpenAlexW2613011186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.